Abstract
Photoacoustic imaging (PAI), also referred to as optoacoustic imaging, has shown promise in early-stage clinical trials in a range of applications from inflammatory diseases to cancer. While the first PAI systems have recently received regulatory approvals, successful adoption of PAI technology into healthcare systems for clinical decision making must still overcome a range of barriers, from education and training to data acquisition and interpretation. The International Photoacoustic Standardisation Consortium (IPASC) undertook an community exercise in 2022 to identify and understand these barriers, then develop a roadmap of strategic plans to address them. Here, we outline the nature and scope of the barriers that were identified, along with short-, medium- and longterm community efforts required to overcome them, both within and beyond the IPASC group.
| Original language | English |
|---|---|
| Article number | 100539 |
| Pages (from-to) | 100539 |
| Number of pages | 14 |
| Journal | Photoacoustics |
| Volume | 32 |
| Early online date | 2 Aug 2023 |
| DOIs | |
| Publication status | Published - Aug 2023 |
Bibliographical note
Funding: This work was funded by UKRI grant EP/V027069/1Copyright © 2023 The Authors. Published by Elsevier GmbH. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/)
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- photoacoustic imaging
- optoacoustic tomography
- standardisation
- quality assurance
- phantoms
- clinical translation
Fingerprint
Dive into the research topics of 'A review of a strategic roadmapping exercise to advance clinical translation of photoacoustic imaging: From current barriers to future adoption'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver